BPR1J-097

• Description :

  BPR1J-097 is a novel potent FLT3 inhibitor with an IC50 of 11 nM.

• UNSPSC :

  12352005

• Hazard Statement :

  H302-H315-H320-H335

• Target :

  FLT3

• Type :

  Reference compound

• Related Pathways :

  Protein Tyrosine Kinase/RTK

• Applications :

  Cancer-Kinase/protease

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/BPR1J-097.html

• Solubility :

  10 mM in DMSO

• Smiles :

  O=C(NC1=NNC(C2=CC=CC(NS(=O)(C3=CC=CC=C3)=O)=C2)=C1)C4=CC=C(N5CCN(C)CC5)C=C4

• Molecular Formula :

  C27H28N6O3S

• Molecular Weight :

  516.61

• Precautions :

  P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

• References & Citations :

  [1]Lin WH, et al. BPR1J-097, a novel FLT3 kinase inhibitor, exerts potent inhibitory activity against AML. Br J Cancer. 2012 Jan 31;106 (3) :475-81.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [1327167-19-0]